Clinical Trial Update: Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating autologous bone marrow-derived cells for muscular dystrophy, including Duchenne muscular dystrophy. The status of the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy
• Muscular Dystrophy

Drugs mentioned

• Autologous bone marrow-derived cells (bone marrow-derived cells)

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Muscular Dystrophy, Duchenne Muscular Dystrophy, | Phase 1, Phase 2 | Status: UNKNOWN